CLASS II Drug recall · Reported 13 Feb 2013 · FDA Enforcement Report

Carisoprodol Tablets, USP, 350 mg recalled by West-ward Pharmaceutical

West-ward Pharmaceutical is recalling Carisoprodol Tablets, USP, 350 mg, distributed nationwide in the US. The recall was initiated on 7 Dec 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 69364A, 69365A, and 69365B, Exp 10/15
Quantity recalled8,585 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-150-2013
FDA event ID
64103
Recalling firm
West-ward Pharmaceutical, Eatontown, NJ
Classification
Class II
Status
Terminated
Recall initiated
7 Dec 2012
FDA classified
5 Feb 2013
Reported
13 Feb 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

7 Dec 2012Recall initiated by company
5 Feb 2013Classified by FDA+60 days
13 Feb 2013Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Substance: Uncharacteristic blacks spots on tablets.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Carisoprodol Tablets, USP, 350 mg, packaged in a) 500-count tablets per bottle (NDC 0143-1176-05) and b) 1000-count tablets per bottle (NDC 0143-1176-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Presence of Foreign Substance: Uncharacteristic blacks spots on tablets.

Which lots are affected?

Lot #: 69364A, 69365A, and 69365B, Exp 10/15

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from West-ward Pharmaceutical

All 30

Other Carisoprodol recalls

All 5